Exchange: NASDAQ·Updated 04:41 PM EDT
News
all
press releases
Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update PR Newswire PRINCETON, N.J., Aug. 6, 2026 Highlighting Four Independent Drivers...
PR Newswire
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J., July 20, 2026 PRINCETON, N.J., July 20, 2026 /PRNewswire/ -- CytoSorbents...
PR Newswire
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
read more...
Benzinga
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and...
PR Newswire
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business...
PR Newswire
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical...
PR Newswire
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent...
PR Newswire
What Analysts Are Saying About CytoSorbents Stock
read more...
Benzinga

Advertisement|Remove ads.